Guided Therapeutics (GTHP) Long-Term Debt Issuances (2012 - 2025)

Guided Therapeutics recorded quarterly Long-Term Debt Issuances of -$303000.0 in Q4 2025, down 380.56% quarter-over-quarter from $108000.0 in Q3 2025, and down 27.85% year-over-year from -$419947.4 in Q4 2024.

Guided Therapeutics' Long-Term Debt Issuances history runs 13 years deep, the most recent figure standing at -$303000.0 for Q4 2025.

  • In Q4 2025, Long-Term Debt Issuances fell 27.85% year-over-year to -$303000.0; the TTM figure through Dec 2025 stood at $160000.0 (up 113.33% YoY), while the FY2025 annual figure was $160000.0, up 113.33% from the prior year.
  • Long-Term Debt Issuances came in at -$303000.0 for Q4 2025 at Guided Therapeutics, down from $108000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $1.4 million in Q3 2022 to a low of -$1.4 million in Q4 2022.
  • A 4-year average of $43900.0 and a median of $131000.0 in 2024 frame the typical range for Long-Term Debt Issuances.
  • Across the five-year window, Long-Term Debt Issuances jumped 584.31% in 2022 and dropped 27.85% in 2025, its largest moves.
  • Guided Therapeutics' Long-Term Debt Issuances stood at $204000.0 in 2021, then tumbled by 784.31% to -$1.4 million in 2022, then jumped by 83.02% to -$237000.0 in 2024, then fell by 27.85% to -$303000.0 in 2025.
  • According to Business Quant data, Long-Term Debt Issuances over the past three periods registered -$303000.0, $108000.0, and $150000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 19.86 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 11.71 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 1.15 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Guided Therapeutics - - 458,000.00 -303,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -303,000.00
Dec 31, 2025 -303,000.00
Sep 30, 2025 108,000.00
Sep 30, 2025 108,000.00
Jun 30, 2025 150,000.00
Jun 30, 2025 150,000.00
Mar 31, 2025 205,000.00
Mar 31, 2025 205,000.00
Dec 31, 2024 -237,000.00
Dec 31, 2024 -237,000.00
Sep 30, 2024 112,000.00
Sep 30, 2024 112,000.00
Jun 30, 2024 200,000.00
Jun 30, 2024 200,000.00
Dec 31, 2022 -1.40 Mn
Dec 31, 2022 -1.40 Mn
Sep 30, 2022 1.40 Mn
Sep 30, 2022 1.40 Mn
Sep 30, 2021 204,000.00
Sep 30, 2021 204,000.00
Jun 30, 2020 519,000.00
Jun 30, 2020 519,000.00
Dec 31, 2019 603,000.00
Dec 31, 2019 603,000.00
Sep 30, 2019 274,000.00
Sep 30, 2019 274,000.00
Jun 30, 2019 244,000.00
Jun 30, 2019 244,000.00
Mar 31, 2019 230,000.00
Mar 31, 2019 230,000.00
Dec 31, 2018 264,000.00
Dec 31, 2018 264,000.00
Sep 30, 2018 415,000.00
Sep 30, 2018 415,000.00
Jun 30, 2018 275,000.00
Jun 30, 2018 275,000.00
Mar 31, 2018 432,000.00
Mar 31, 2018 432,000.00
Dec 31, 2017 -746,000.00
Dec 31, 2017 -746,000.00
Sep 30, 2017 350,000.00
Sep 30, 2017 350,000.00
Jun 30, 2017 184,000.00
Jun 30, 2017 184,000.00
Mar 31, 2017 212,000.00
Mar 31, 2017 212,000.00
Dec 31, 2016 239,000.00
Dec 31, 2016 239,000.00
Sep 30, 2016 101,000.00
Sep 30, 2016 101,000.00
Jun 30, 2016 589,000.00
Jun 30, 2016 589,000.00
Mar 31, 2016 1.03 Mn
Mar 31, 2016 1.03 Mn
Dec 31, 2015 -38,000.00
Dec 31, 2015 -38,000.00
Sep 30, 2015 212,000.00
Sep 30, 2015 212,000.00
Jun 30, 2015 141,000.00
Jun 30, 2015 141,000.00
Mar 31, 2015 62,000.00
Mar 31, 2015 62,000.00
Dec 31, 2014 692,000.00
Dec 31, 2014 692,000.00
Sep 30, 2014 1.38 Mn
Sep 30, 2014 1.38 Mn
Jun 30, 2014 2.82 Mn
Jun 30, 2014 2.82 Mn
Mar 31, 2014 378,000.00
Mar 31, 2014 378,000.00
Dec 31, 2013 115,000.00
Dec 31, 2013 115,000.00
Dec 31, 2012 86,000.00
Dec 31, 2012 86,000.00